On September 12, 2023 Carina Biotech, a cell therapy immuno-oncology company, reported that it will be presenting at the 7th Annual Cell and Gene Therapy World Asia 2023 Conference in Singapore on 14-15 September (Press release, Carina Biotech, SEP 13, 2023, View Source;utm_medium=rss&utm_campaign=press-release-carina-to-present-at-7th-annual-cell-and-gene-therapy-world-asia-2023-conference [SID1234635096]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference attracts more than 300 cell and gene therapy professionals from over 150 companies. The conference is an opportunity for Asia-Pacific companies to connect with leading global cell and gene therapy companies and big pharma in networking and speaking sessions.

Chief Executive Officer Dr Deborah Rathjen will be presenting Carina’s success in taking its lead CAR-T asset CNA3103 from preclinical development through to clinical trials. Dr Rathjen will also be participating in a leadership panel discussion to share her extensive experience in biotech and pharmaceutical industries locally and internationally.